Neal Walker

Track

Insider profile

Currently holds positions in Aldeyra Therapeutics Inc and Aclaris Therapeutics Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 98% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Aldeyra Therapeutics Inc June 1, 2013 -
President, Chief Executive Officer, Co-Founder, Director Aclaris Therapeutics Inc July 1, 2012 -
Neal Walker's trades of Aclaris Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
2.55
Quantity 9,804
Value £25,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-03 2023-03-03
S Sale
52,343 -45.4%
293.24
US$1,956,105 		52,343 -45.4% 293.24 US$1,956,105
2023-03-03 2023-03-02
S Sale
20,117 -24.5%
247.98
US$4,044,887 		20,117 -24.5% 247.98 US$4,044,887
2023-02-03 2023-02-02
PlS Planned sale
17,303 -35.1%
448.47
US$2,644,936 		17,303 -35.1% 448.47 US$2,644,936
2023-02-03 2023-02-02
PlS Planned sale
3,121 -0.3%
16.88
US$52,691 		3,121 -0.3% 16.88 US$52,691
2023-02-03 2023-02-02
PlS Planned sale
600 -0.1%
15.55
US$9,332 		600 -0.1% 15.55 US$9,332
2023-02-03 2023-02-02
PlS Planned sale
1,079 -0.1%
14.57
US$15,718 		1,079 -0.1% 14.57 US$15,718
2023-02-03 2023-02-01
PlS Planned sale
25,000 -2.1%
16.75
US$418,675 		25,000 -2.1% 16.75 US$418,675
2023-01-04 2023-01-04
PlS Planned sale
15,000 -1.2%
14.89
US$223,342 		15,000 -1.2% 14.89 US$223,342
2023-01-04 2023-01-03
PlS Planned sale
1,618 -0.1%
16.16
US$26,146 		1,618 -0.1% 16.16 US$26,146
2023-01-04 2023-01-03
PlS Planned sale
23,382 -1.9%
15.19
US$355,067 		23,382 -1.9% 15.19 US$355,067
2022-04-25 2022-04-25
PlS Planned sale
20,000 -1.6%
15.18
US$303,656 		20,000 -1.6% 15.18 US$303,656
2022-04-25 2022-04-22
PlS Planned sale
25,000 -1.9%
15.04
US$376,098 		25,000 -1.9% 15.04 US$376,098
2022-04-25 2022-04-21
PlS Planned sale
25,000 -1.9%
15.24
US$380,948 		25,000 -1.9% 15.24 US$380,948
2022-03-14 2022-03-11
S Sale
56,303 -4.1%
15.91
US$896,045 		56,303 -4.1% 15.91 US$896,045
2022-02-11 2022-02-09
S Sale
3,595 -0.3%
12.66
US$45,513 		3,595 -0.3% 12.66 US$45,513
2021-06-02 2021-06-02
S Sale
5,517 -0.4%
22.30
US$123,038 		5,517 -0.4% 22.30 US$123,038
2021-06-02 2021-06-02
S Sale
27,743 -2.2%
21.51
US$596,696 		27,743 -2.2% 21.51 US$596,696
2021-04-26 2021-04-22
PlS Planned sale
30,000 -2.5%
26.84
US$805,239 		30,000 -2.5% 26.84 US$805,239
2018-02-09 2008-02-18
B Purchase
9,804
2.55
£25,000 		9,804 2.55 £25,000